Dr Natalia Povolotskaya
Consultant Gynaecologist and Cancer Surgeon
MRCOG, Dip MedEd, FHEA
I offer rapid and individualised diagnosis and treatment of gynaecological cancers and complex benign gynaecological issues. I offer a broad range of surgery, this includes minimal access and open surgery. Minimal access surgery allows me to minimise my patients hospital stay and accelerate their recovery even in complex situations.
Since graduating with Distinction in my medical degree in 1997, I have dedicated my life to developing broad expertise in Obstetrics, Gynaecology and Gynaecological Oncology.
I have worked with some of the best surgeons during my training in the Southwest and the Southeast of England. I have GMC accreditation in Obstetrics and Gynaecology. And Gynaecological Oncology as a subspecialty (subspecialisation requiring completion of a further three years of subspeciality training).
I have been a Consultant in Gynaecological Oncology since 2015. And have performed hundreds of complex surgeries. Some of my work has been featured on the Channel 4 programme “Shut-Ins”, (Episode “Claire’s Story”).
In my previous position as Chair of Wessex Gynaecological Cancer NetWork (2019-2022). I supported the Regional Audit on Ovarian Cancer and the setup of the Regional Genetics Multidisciplinary Meeting for familial gynecological cancers.
I now train the next generation of subspecialty trainees in Gynaeoncology in my capacity as an RCOG recognised Supervisor of Sub-speciality training in Gynaecological Oncology and a Colposcopy Trainer.
I dedicate a significant part of my time to clinical research. I was a Principal Investigator for the now-completed FORECEE and SUCCOR studies. And am currently a Principal Investigator for the PROTECTOR study. I also have multiple medical publications.
Some of the principal treatments carried out by Dr Natalia Povolotskaya at Spire include:
Rapid Diagnosis and treatment of:
Gynaecological cancer surgery
Gynaecological cancer screening / risk reduction surgery for familial gynaecological cancers
Fertility sparing surgery
COVID-19 testing or antibody tests are not available as a standalone service at Spire Portsmouth Hospital.
MBBS / St Petersburg Pavlov Medical University, Russian Federation / 1997
Bachelor of Medicine
Supervisor of Subspeciality Training in Gynaecological Oncology
Wessex Gynaecological Cancer NetWork Chair 2019 - 2022
Clinical Governance Lead in Gynaecology 2017 - 2019
Utility of Preoperative CA125 Assay in the Management Planning of Women Diagnosed with Uterine Cancer N. Povolotskaya,* N. Das, K. Dhar, D. Brinkmann, F. Gardner, and R. Woolas
Implementation of a robotic surgical program in gynaecological oncology and comparison with prior laparoscopic series. Povolotskaya N, Woolas R, Brinkmann D.Int J Surg Oncol. 2015;2015:814315. doi: 10.1155/2015/814315. Epub 2015 Feb 15
The diagnosis of endometrial atypia by hysteroscopy with guided biopsy in postmenopausal patients with hyperplasia: a reliable practice?Siavash Rahimi, Carla Marani, Maria Emanuela Natale, Renato Zeloni, Raffaella Ruggeri, Natalia Povolotskaya & Robert Woolas
Post-coital bleeding: What is the incidence of significant gynaecological pathology in women referred for colposcopy? Godfrey MAL, Nikolopoulos M, Povolotskaya N, Chenoy R, Wuntakal R.Sex Reprod Healthc. 2019 Dec;22:100462. doi: 10.1016/j.srhc.2019.100462. Epub 2019 Sep 23.PMID: 31563734
SUCCOR study: an international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 cervical cancer. Chiva L, et al; SUCCOR study Group. Int J Gynecol Cancer. 2020 Sep;30(9):1269-1277. doi: 10.1136/ijgc-2020-001506. Epub 2020 Aug 11.PMID: 32788262
Preventing Ovarian Cancer through early Excision of Tubes and late Ovarian Removal (PROTECTOR): protocol for a prospective non-randomised multi-center trial. Gaba F, Robbani S, Singh N, McCluggage WG, Wilkinson N, Ganesan R, Bryson G, Rowlands G, Tyson C, Arora R, Saridogan E, Hanson H, Burnell M, Legood R, Evans DG, Menon U, Manchanda R; PROTECTOR team. Int J Gynecol Cancer. 2021 Feb;31(2):286-291. doi: 10.1136/ijgc-2020-001541. Epub 2020 Sep 8.PMID: 32907814
SUCCOR cone study: conization before radical hysterectomy. Chacon E, SUCCOR study Group. Int J Gynecol Cancer. 2022 Feb;32(2):117-124. doi: 10.1136/ijgc-2021-002544. Epub 2022 Jan 17.PMID: 35039455
SUCCOR Risk: Design and Validation of a Recurrence Prediction Index for Early-Stage Cervical Cancer. Manzour N, Chiva L, Chacón E, Martin-Calvo N, Boria F, Minguez JA, Alcazar JL; SUCCOR Study Group. Ann Surg Oncol. 2022 Aug;29(8):4819-4829. doi: 10.1245/s10434-022-11671-5. Epub 2022 Apr 16.PMID: 35430668 Free PMC article.
Surgical decision making in premenopausal BRCA carriers considering risk-reducing early salpingectomy or salpingo-oophorectomy: a qualitative study. Gaba F, Goyal S, Marks D, Chandrasekaran D, Evans O, Robbani S, Tyson C, Legood R, Saridogan E, McCluggage WG, Hanson H, Singh N, Evans DG, Menon U, Manchanda R; PROTECTOR team. J Med Genet. 2022 Feb;59(2):122-132. doi: 10.1136/jmedgenet-2020-107501. Epub 2021 Feb 10.PMID: 33568437 Free PMC artic